GoRoga’s Cranial Electrotherapy Stimulation (CES) technology has been scientifically evaluated in India’s first published clinical study on anxiety management. Conducted at Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai, and published in the Annals of Indian Psychiatry (2025), this research provides strong evidence of GoRoga’s effectiveness in Indian patients.
STRESS RESILIENCE
Indian Studies
First-of-its-kind Indian
Clinical Study on GoRoga
Study Design
- Sample Size: 100 patients, aged 18 - 80 years
- Conditions Studied: Major Depressive Disorder with anxious distress, Panic Disorder, Generalized Anxiety Disorder, Adjustment Disorder with Anxiety
- Intervention: Single 20-minute GoRoga CES session (mastoid placement)
- Parameters Measured: Blood Pressure, Heart Rate, Oxygen Saturation, Subjective Anxiety (Visual Analog Scale - VAS)
Key Findings
Immediate Reduction in Anxiety – Significant drop in subjective anxiety scores (GAD-7) from 7.15 → 3.46 after just one session. Physiological Improvements –
Safe & Well-Tolerated-
No major side effects reported.
 Presession Postsession t P (3).png)
Clinical Significance
This Indian study confirms that GoRoga CES:
- Works within minutes
- Provides drug-free relief from anxiety symptoms
- Can be used safely alongside existing treatments
- Is suitable for clinical and home settings
Published Reference
- Choosing a selection results in a full page refresh.
- Opens in a new window.